Infectious Disease Archives | 第 2 页，共 7 页 | Certara

Blog

Applying decision analysis to drug development for COVID-19 & future pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions under…

Certara2020 年 4 月 30 日

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Certara2020 年 1 月 17 日

Publication

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing

Certara2020 年 1 月 17 日

Poster

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

Certara2019 年 6 月 24 日

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

Certara2019 年 6 月 24 日

Publication

A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole

Certara2018 年 7 月 1 日

Publication

Pharmacokinetics of Praziquantel in Schistosoma Mansoni- and Schistosoma Haematobium-infected School- and Preschool-aged Children

Certara2018 年 6 月 4 日

Publication

Population Pharmacokinetics of Intravenous Linezolid in Premature Infants

Certara2018 年 4 月 9 日

Publication

Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations

Certara2018 年 4 月 1 日

Publication

Population Pharmacokinetics of Teicoplanin in Hospitalized Elderly Patients Using Cystatin C as an Indicator of Renal Function

Certara2018 年 4 月 1 日

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software